PuSH - Publication Server of Helmholtz Zentrum München

Glucocorticoids augment survival and proliferation of tumor cells.

Anticancer Res. 32, 4251-4261 (2012)
Publ. Version/Full Text Volltext PMC
Free by publisher
Open Access Green as soon as Postprint is submitted to ZB.
BACKGROUND: Glucocorticoids are widely used for cancer patients, although they can reduce the efficacy of anticancer treatment. MATERIALS AND METHODS: We characterized non-apoptotic actions of glucocorticoids on tumor cell lines, primary tumor cells and an in vivo model, together with molecular signaling studies. RESULTS: Glucocorticoids enhanced cell proliferation in 9/17 cell lines and significantly promoted tumor cell proliferation in a pre-clinical mouse model of lung carcinoma. 65/139 primary acute childhood leukemia samples were glucocorticoid-resistant. Both dexamethasone and prednisolone increased in vitro survival in 21/65 samples from glucocorticoid-resistant primary leukemias, revealing a completely new action of glucocorticoids. Dexamethasone-induced proliferation was mediated by glucocorticoid receptor and activated the proliferation signaling pathways of protein kinase B/AKT and p38 mitogen-activated protein kinase. CONCLUSION: Our data suggest that restriction of the use of glucocorticoids during anticancer treatment might improve the outcome of patients with solid tumors.
Altmetric
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Corresponding Author
Keywords Tumor cell proliferation; glucocorticoids; glucocorticoid receptor; p38MAPK; AKT; ACUTE LYMPHOBLASTIC-LEUKEMIA; INDUCED APOPTOSIS; BRAIN METASTASES; LUNG-CANCER; DEXAMETHASONE; RECEPTOR; PHARMACOKINETICS; PREDNISOLONE; STIMULATION; PACLITAXEL
ISSN (print) / ISBN 0250-7005
e-ISSN 1791-7530
Quellenangaben Volume: 32, Issue: 10, Pages: 4251-4261 Article Number: , Supplement: ,
Publisher International Institute of Anticancer Research
Non-patent literature Publications
Reviewing status Peer reviewed